vs
American Bitcoin Corp.（ABTC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是American Bitcoin Corp.的1.7倍（$197.9M vs $118.0M），American Bitcoin Corp.同比增速更快（151.5% vs 13.6%），过去两年American Bitcoin Corp.的营收复合增速更高（296.9% vs 14.4%）
美国比特币公司专注于比特币相关业务领域。比特币是首个去中心化加密货币，由化名为中本聪的匿名人士于2008年发布白皮书后诞生，2009年随着开源代码上线正式投入使用，问世以来对全球金融与数字货币领域都产生了极为深远的影响。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ABTC vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$118.0M
营收增速更快
ABTC
高出137.9%
13.6%
两年增速更快
ABTC
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $118.0M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | 49.1% | 52.5% |
| 营业利润率 | -192.8% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 151.5% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $-0.07 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTCRGEN
| Q4 25 | $118.0M | $197.9M | ||
| Q3 25 | $64.2M | $188.8M | ||
| Q2 25 | $1.4M | $182.4M | ||
| Q1 25 | $1.6M | $169.2M | ||
| Q4 24 | $46.9M | $174.1M | ||
| Q3 24 | $11.6M | $154.9M | ||
| Q2 24 | $5.5M | $154.1M | ||
| Q1 24 | $7.5M | $151.3M |
净利润ABTCRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $3.5M | $14.9M | ||
| Q2 25 | $3.4M | $14.9M | ||
| Q1 25 | $-100.6M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $-576.0K | $-654.0K | ||
| Q2 24 | $-61.1M | $3.3M | ||
| Q1 24 | $230.4M | $2.1M |
毛利率ABTCRGEN
| Q4 25 | 49.1% | 52.5% | ||
| Q3 25 | 56.0% | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | 57.9% | 26.1% | ||
| Q3 24 | 4.2% | 50.0% | ||
| Q2 24 | 31.0% | 49.8% | ||
| Q1 24 | 35.4% | 49.5% |
营业利润率ABTCRGEN
| Q4 25 | -192.8% | 9.0% | ||
| Q3 25 | 11.2% | 8.9% | ||
| Q2 25 | -162.1% | 7.6% | ||
| Q1 25 | -350.8% | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | -87.8% | -5.1% | ||
| Q2 24 | -106.4% | 1.0% | ||
| Q1 24 | -20.8% | 1.3% |
净利率ABTCRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 5.4% | 7.9% | ||
| Q2 25 | 249.2% | 8.2% | ||
| Q1 25 | -6458.5% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | -5.0% | -0.4% | ||
| Q2 24 | -1107.2% | 2.2% | ||
| Q1 24 | 3076.2% | 1.4% |
每股收益（稀释后）ABTCRGEN
| Q4 25 | $-0.07 | $0.24 | ||
| Q3 25 | $0.06 | $0.26 | ||
| Q2 25 | $-0.07 | $0.26 | ||
| Q1 25 | $-0.09 | $0.10 | ||
| Q4 24 | $1.10 | $-0.55 | ||
| Q3 24 | $-0.15 | $-0.01 | ||
| Q2 24 | $-0.10 | $0.06 | ||
| Q1 24 | $-0.36 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $665.8M | $2.1B |
| 总资产 | $1.2B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ABTCRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | $750.0K | $708.9M | ||
| Q1 25 | $367.0K | $697.2M | ||
| Q4 24 | $850.0K | $757.4M | ||
| Q3 24 | $478.0K | $784.0M | ||
| Q2 24 | $1.4M | $809.1M | ||
| Q1 24 | $1.9M | $780.6M |
总债务ABTCRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABTCRGEN
| Q4 25 | $665.8M | $2.1B | ||
| Q3 25 | $575.5M | $2.1B | ||
| Q2 25 | $339.7M | $2.1B | ||
| Q1 25 | $115.8M | $2.0B | ||
| Q4 24 | $1.0B | $2.0B | ||
| Q3 24 | $697.5M | $2.0B | ||
| Q2 24 | $614.3M | $2.0B | ||
| Q1 24 | $696.8M | $2.0B |
总资产ABTCRGEN
| Q4 25 | $1.2B | $2.9B | ||
| Q3 25 | $1.2B | $2.9B | ||
| Q2 25 | $6.2M | $2.9B | ||
| Q1 25 | $9.0M | $2.9B | ||
| Q4 24 | $1.1B | $2.8B | ||
| Q3 24 | $7.5M | $2.8B | ||
| Q2 24 | $11.4M | $2.9B | ||
| Q1 24 | $17.8M | $2.8B |
负债/权益比ABTCRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-79.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流ABTCRGEN
| Q4 25 | $-79.6M | $25.7M | ||
| Q3 25 | $-39.0M | $48.1M | ||
| Q2 25 | $-879.0K | $28.6M | ||
| Q1 25 | $-3.2M | $15.0M | ||
| Q4 24 | $-54.0M | $39.2M | ||
| Q3 24 | $-76.8M | $49.3M | ||
| Q2 24 | $201.0K | $42.2M | ||
| Q1 24 | $-983.0K | $44.7M |
自由现金流ABTCRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | $-1.4M | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | $-60.6M | $33.6M | ||
| Q3 24 | $-79.3M | $42.3M | ||
| Q2 24 | $-874.0K | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率ABTCRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | -104.4% | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | -129.2% | 19.3% | ||
| Q3 24 | -683.2% | 27.3% | ||
| Q2 24 | -15.8% | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度ABTCRGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | 40.5% | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | 14.1% | 3.2% | ||
| Q3 24 | 21.6% | 4.5% | ||
| Q2 24 | 19.5% | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率ABTCRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | -11.21× | 3.23× | ||
| Q2 25 | -0.26× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | -0.00× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
